---
figid: PMC3746754__nihms479301f2
figlink: /pmc/articles/PMC3746754/figure/F2/
number: F2
caption: Transferrin has two iron binding sites which have high affinity for Fe (III).
  Diferric transferrin binds to transferrin receptor-1 (TrF-1) which is then endocytosed.
  The endocytic vesicle is acidified by the actions of a vesicular ATPase (V-ATPase)
  which is a proton pump, actively moving H+ into the vesicle. At low pH, transferrin
  releases its cargo of iron which can leave the endocytic vesicle either through
  ferroportin or by co-transport with H+ through the divalent metal transporter-1
  (DMT1). Iron may then transit through what is called the labile iron pool (LIP)
  to sites of storage or utilization, or may leave the cell through ferroportin present
  in the plasma membrane. Iron can also enter the LIP from heme which is broken down
  by heme oxygenase. Iron brought into the cells can regulate the activities of the
  iron regulatory proteins-1 and -2 (), which in turn regulate proteins involved in
  iron metabolism. It can also be chaperoned by PCBP1 to safe storage in ferritin.
  The protein hepcidin regulates ferroportin levels by triggering its degradation.
  In turn, hepcidin is regulated by HFE which triggers an increase in hepcidin synthesis.
  HFE is normally bound to transferrin receptor-1 (TfR-1), but the binding site is
  also recognized by diferric transferrin which competes with HFE for binding. The
  HFE is released and binds to transferrin receptor-2 (TfR-2) which triggers a signaling
  pathway up-regulating hepcidin. The movement of iron out of the cell by ferroportin
  is enhanced by the ferroxidase activities of ceruloplasmin (Cp) and/or hephaestin.
  In this figure, dotted lines indicate movement and solid lines indicate descriptors.
  The labile iron pool (LIP) is surrounded by a dotted line indicating that the LIP
  is not a discrete entity located within an organelle, but likely exists throughout
  the cytoplasm.
pmcid: PMC3746754
papertitle: Iron metabolism in the eye, a review.
reftext: M. Goralska, et al. Exp Eye Res. ;88(2):204-215.
pmc_ranked_result_index: '55436'
pathway_score: 0.5039508
filename: nihms479301f2.jpg
figtitle: Iron metabolism in the eye, a review
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3746754__nihms479301f2.html
  '@type': Dataset
  description: Transferrin has two iron binding sites which have high affinity for
    Fe (III). Diferric transferrin binds to transferrin receptor-1 (TrF-1) which is
    then endocytosed. The endocytic vesicle is acidified by the actions of a vesicular
    ATPase (V-ATPase) which is a proton pump, actively moving H+ into the vesicle.
    At low pH, transferrin releases its cargo of iron which can leave the endocytic
    vesicle either through ferroportin or by co-transport with H+ through the divalent
    metal transporter-1 (DMT1). Iron may then transit through what is called the labile
    iron pool (LIP) to sites of storage or utilization, or may leave the cell through
    ferroportin present in the plasma membrane. Iron can also enter the LIP from heme
    which is broken down by heme oxygenase. Iron brought into the cells can regulate
    the activities of the iron regulatory proteins-1 and -2 (), which in turn regulate
    proteins involved in iron metabolism. It can also be chaperoned by PCBP1 to safe
    storage in ferritin. The protein hepcidin regulates ferroportin levels by triggering
    its degradation. In turn, hepcidin is regulated by HFE which triggers an increase
    in hepcidin synthesis. HFE is normally bound to transferrin receptor-1 (TfR-1),
    but the binding site is also recognized by diferric transferrin which competes
    with HFE for binding. The HFE is released and binds to transferrin receptor-2
    (TfR-2) which triggers a signaling pathway up-regulating hepcidin. The movement
    of iron out of the cell by ferroportin is enhanced by the ferroxidase activities
    of ceruloplasmin (Cp) and/or hephaestin. In this figure, dotted lines indicate
    movement and solid lines indicate descriptors. The labile iron pool (LIP) is surrounded
    by a dotted line indicating that the LIP is not a discrete entity located within
    an organelle, but likely exists throughout the cytoplasm.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CP
  - TFRC
  - HFE
  - TFR2
  - PCBP1
  - IREB2
  - ACO1
  - SMG1
genes:
- word: Cp
  symbol: CP
  source: hgnc_symbol
  hgnc_symbol: CP
  entrez: '1356'
- word: Tfr-1
  symbol: TFR1
  source: hgnc_alias_symbol
  hgnc_symbol: TFRC
  entrez: '7037'
- word: HFE
  symbol: HFE
  source: hgnc_symbol
  hgnc_symbol: HFE
  entrez: '3077'
- word: Tfr-2
  symbol: TFR2
  source: hgnc_symbol
  hgnc_symbol: TFR2
  entrez: '7036'
- word: PCBP1
  symbol: PCBP1
  source: hgnc_symbol
  hgnc_symbol: PCBP1
  entrez: '5093'
- word: IRP1&2
  symbol: IRP2
  source: hgnc_alias_symbol
  hgnc_symbol: IREB2
  entrez: '3658'
- word: IRP1
  symbol: IRP1
  source: hgnc_alias_symbol
  hgnc_symbol: ACO1
  entrez: '48'
- word: Lá»ŠP
  symbol: LIP
  source: hgnc_alias_symbol
  hgnc_symbol: SMG1
  entrez: '23049'
chemicals: []
diseases: []
figid_alias: PMC3746754__F2
redirect_from: /figures/PMC3746754__F2
figtype: Figure
---
